An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Investigator: Bincy Abraham, MD

Study Coordinator:

Status: Enrolling

ClinicalTrials.gov Number: NCT03467958

Phone:

Protocol Number: Pro00019983

Description

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials